Clinical Research Directory
Browse clinical research sites, groups, and studies.
The SUMMIT Study: A Cancer Screening Study
Sponsor: University College, London
Summary
The SUMMIT Study will enrol 13,000 participants in order to investigate how cancer screening can be improved and delivered. The SUMMIT Study has two main aims: the first is to clinically validate a blood test for detecting multiple cancers at an early stage. The second is to examine the feasibility of delivering a low-dose CT (LDCT) screening service for lung cancer to a high-risk population in North Central and East London.
Official title: The SUMMIT Study: Cancer Screening Study With or Without Low Dose Lung CT to Validate a Multi-cancer Early Detection Test
Key Details
Gender
All
Age Range
55 Years - 77 Years
Study Type
OBSERVATIONAL
Enrollment
13035
Start Date
2019-04-08
Completion Date
2030-08
Last Updated
2024-12-05
Healthy Volunteers
Yes
Conditions
Interventions
Low Dose CT scan
Low Dose chest CT scan conferring an equivalent radiation dose of less than 2 mSv to the average size patient. The study aims to keep most scans under 1 mSv (ultra-low dose), and all scans under 2 mSv.
Locations (1)
UCLH
London, United Kingdom